Harold Joseph Holliday, MD | |
1005 W Madison Ave, Athens, TN 37303-3433 | |
(423) 744-7540 | |
(423) 745-4898 |
Full Name | Harold Joseph Holliday |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 51 Years |
Location | 1005 W Madison Ave, Athens, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740270883 | NPI | - | NPPES |
3198966 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MD008595 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Starr Regional Medical Center Athens | Athens, TN | Hospital |
Mailing Address | Practice Location Address |
---|---|
Harold Joseph Holliday, MD 1005 W Madison Ave, Athens, TN 37303-3433 Ph: (423) 744-7540 | Harold Joseph Holliday, MD 1005 W Madison Ave, Athens, TN 37303-3433 Ph: (423) 744-7540 |
News Archive
In an analysis of genetic information among more than 87,000 men, a global team of scientists says it has found 23 new genetic variants - common differences in the genetic code - that increase a man's risk for prostate cancer. The so-called "meta-analysis," believed to be the largest of its kind, has revealed once hidden mutations among men in a broad array of ethnic groups comprising men of European, African, Japanese and Latino ancestry.
In a groundbreaking study that provides scientists with a critical new understanding of stem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first-of-its-kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embryo.
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Alexion Pharmaceuticals, Inc. today announced financial results for the three and six months ended June 30, 2010.
RainDance Technologies, Inc., the Digital Biology Company, and Ambry Genetics, today announced the launch of a comprehensive targeted sequencing panel to screen genes involved with drug absorption, distribution, metabolism, and excretion (ADME) research. The ADMESeq Research Screening Panel enables researchers to simultaneously interrogate 242 known pharmacogenetic genes using next-generation sequencing (NGS) systems.
› Verified 9 days ago
Nicholas Ballay, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 719 Cook Dr, Athens, TN 37303 Phone: 423-745-2344 Fax: 423-745-2314 | |
Preston W Brown, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 719 Cook Dr, Ste 109, Athens, TN 37303 Phone: 423-745-2344 Fax: 423-745-2314 | |
Thomas S Layman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 719 Cook Dr, Suite 110, Athens, TN 37303 Phone: 423-745-2344 Fax: 423-745-2314 | |
Michael P Sumida, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 719 Cook Dr, Ste 109, Athens, TN 37303 Phone: 423-745-2344 Fax: 423-745-2314 | |
Charles Boggess Cox, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 503 W Madison Ave, Athens, TN 37303 Phone: 423-745-2312 Fax: 423-746-0687 |